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Abstract Factor structure analyses have revealed the
presence of specific biological system markers in
healthy humans and diseases. However, this type of
approach in very old persons and in type 2 diabetes
(T2DM) is lacking. A total sample of 2,137 Italians
consisted of two groups: 1,604 healthy and 533 with
T2DM. Age (years) was categorized as adults (≤65),
old (66–85), oldest old (>85–98) and centenarians
(≥99). Specific biomarkers of routine haematological
and biochemical testing were tested across each age
group. Exploratory factorial analysis (EFA) by principal
component method with Varimax rotation was used to
identify factors including related variables. Structural
equation modelling (SEM) was applied to confirm
factor solutions for each age group. EFA and SEM
identified specific factor structures according to age
in both groups. An age-associated reduction of factor
structure was observed from adults to oldest old in
the healthy group (explained variance 60.4% vs
50.3%) and from adults to old in the T2DM group
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(explained variance 57.4% vs 44.2%). Centenarians
showed three-factor structure similar to those of
adults (explained variance 58.4%). The inflammatory
component became the major factor in old group and
was the first one in T2DM. SEM analysis in healthy
subjects suggested that the glucose levels had an impor-
tant role in the oldest old. Factorial structure change
during healthy ageing was associated with a decrease
in complexity but showed an increase in variability and
inflammation. Structural relationship changes observed
in healthy subjects appeared earlier in diabetic patients
and later in centenarians.
Keywords Ageing . Exploratory factor analysis .
Structural equation modelling . Centenarians . Diabetic
patients
Introduction
Human ageing, characterized by a complex remodelling
of thousands of biological variables necessary for
maximizing the probability of survival, is the product of
genetic, environmental and stochastic factors. Studies
have underlined that age-related effects on specific
biological functioning variables arise from common
causal mechanism and may explain many of the
manifesting outcomes predominantly observed in
old age (Mackinnon et al. 2006; Cevenini et al. 2010).
In order to understand the causal mechanisms of the
human ageing process, the model of ‘centenarians’, a
representative group of successful ageing, has been
identified (Franceschi et al. 2000). Data obtained from
these centenarian studies showed that the ageing process
is characterized by the remodelling of some important
networks, as suggested by the peculiar clinical and
anthropometric characteristics present in very old
(Barbieri et al. 2003). According to the remodelling
theory of age, the peculiar characteristics of centenarians
might be the net result of the continuous adaptation
of the body to deleterious changes over time (Barbieri
et al. 2001). Recently, Yashin et al. showed that
exceptional survival requires dynamic maintenance
of physiological variables at ‘optimal values’. These
indices are not fixed for the entire life course but
change over ageing, suggesting that the determinants
of exceptional survival could have ‘age-trajectories’
rather than fixed values (Yashin et al. 2009). It is now
becoming evident that while genetic differences
contribute modestly to life expectancy before the
age of 60 years, their impact on survival becomes more
prominent at the extreme ages (Franceschi et al. 2007a,
b; Gögele et al. 2011).
Studies of the genetics of human longevity have
consistently found that two genes—APOE (Schachter
et al. 1994) and FOXO3 (Willcox et al. 2008)—are
associated with human longevity. Both of these genes
and the majority of other potential findings that have
emerged during the past decade (de Magalhães et al.
2009a, b; Capri et al. 2006, 2008; Pawlikowska et al.
2009; Bonafè and Olivieri 2009; Singh et al. 2007) are
related mainly to inflammation, stress response or
lipid and glucose metabolism.
These results also confirmed that the imbalance
between inflammatory and anti-inflammatory networks
result in low-grade chronic pro-inflammation, ‘inflam-
maging’which is mainly due to a genetic predisposition
(Franceschi et al. 2007a, b; Franceschi 2007; Salvioli et
al. 2006). Interestingly, a recent meta-analysis of
age-related gene expression profiles revealed several
common signatures of ageing, including overexpression
of inflammation and immune response genes and an
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underexpression of genes associated with lipid and
glucose metabolism (de Magalhães et al. 2009a, b).
Interestingly, even if ageing is associated with a
significant rise in oxidative stress mainly due to a
decline in anti-oxidant activity and a rise in pro-
oxidant factors, centenarians have a significantly
lower degree of oxidative stress (Rabini et al. 2002;
Suzuki et al. 2010). This finding has led investigations
to reveal that specific biomarkers are strongly linked to
glucose metabolism in longevity (Barbieri et al. 2003).
Furthermore, glucose metabolism worsens over ageing
due to an age-related decline in insulin-mediated
glucose uptake. However, glucose metabolism is
maintained in healthy centenarians and has been shown
to be better than that of old adults (Barbieri et al. 2003).
Therefore, one may hypothesize that adults with
type 2 diabetes (T2DM) may have insulin pathway
dysfunctions as older healthy persons. and specific
biomarkers may reveal such trajectory patterns.
In addition to specific markers of glucose and lipid
metabolism, other biomarkers have been included as
useful tools in the evaluation of health status over
ageing (Frisoni et al. 1994; Nakamura and Miyao
2003; Yashin et al. 2009). In particular, total cholesterol
(TC), triglycerides (TG), plasma glucose levels (GLU),
C reactive protein (CRP), fibrinogen (FIBR), white
blood cell count (WBCC) and haemoglobin (Hb) have
been shown to vary over the ageing process (Frisoni
et al. 1994; Nakamura and Miyao 2003).
Previous publications have applied factor or principal
components analysis, a statistical technique used to
study interrelating variables on human ageing pheno-
types and the risk factor clusters in common age-related
human diseases (Nakamura andMiyao 2003; Choi et al.
2003; Hasegawa et al. 2005; Wang et al. 2004; Noale
et al. 2006; Passarino et al. 2007; Khader et al. 2011;
O’Hea et al. 2009). Moreover, this type of analysis has
also been applied to measure systemic inflammatory
status over ageing mainly in middle-aged adults
(Hsu et al. 2009; Riechelmann et al. 2005).
Therefore, the aim of this study was to investigate
the variability using exploratory factorial analysis
(EFA) of specific biomarkers related to inflammation,
glucose and lipid metabolism across different age
groups in a large sample of healthy subjects, including
centenarians and old persons with T2DM. We also
applied structural equation modelling (SEM) to test
for the complexity of these biomarkers over ageing
and disease status.
Materials and methods
Study population
A total of 2,137 people from different Italian regions,
aged from 18 to 111 years, were enrolled to participate
in this study that was financed by Italian Health
Ministry and by the Ministry of Education, University
and Research from 2007 to 2009. The study sample
consisted of 1,325 healthy subjects (n0577 men and
n0748 women, age range 18–98), 279 centenarians
(n053 men and n0226 women, age range 99–
111 years) and 533 participants with T2DM (n0288
men and n0245 women, age range 40–86 years).
Participants were recruited from the I.N.R.C.A. and
five Italian universities including University of Bologna,
University of Florence, University of Milan, University
of Parma and University of Palermo.
Inclusion criteria of the healthy subjects were the
absence of acute (such as acute myocardial infarction)
and chronic diseases (such as Alzheimer and T2DM)
at the time of blood collection and clinical examination.
Information on their health status was assessed by
questionnaires, laboratory assays and physical examina-
tion. The sample of 1,325 healthy subjects was catego-
rized according to age in four groups as follows: adults
(≤65 years) (n0421), old (66–85 years) (n0642), oldest
old (86–98 years) (n0262) and centenarians (>99 years)
(n0279).
T2DM was diagnosed according to the American
Diabetes Association Criteria (American Diabetes
Association 2007). T2DM group was categorized
according to age as follows: adults (≤65 years)
(n0235) and old (66–85 years) (n0298). All subjects
gave their informed consent to participate in the study,
which was approved by the Ethics Committee of
the I.N.R.C.A. and by the Ethical Committee of the
Sant’Orsola-Malpighi Hospital, University of Bologna
for centenarians.
Seven biochemical and haematological parameters
related to lipid, glucose and inflammatory immuno-
logical pathways of ageing were analysed and included
fasting plasma GLU (milligrams per decilitre), TC
(milligrams per decilitre), TG (milligrams per decilitre),
FIBR (milligrams per decilitre), CRP (milligrams per
decilitre), WBCC (103/mm3) and Hb (grams per
decilitre). Haematology and blood chemistry assays
were determined by routine laboratory methods that
did not require standardization of such parameters.
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All tests were performed at the Medical Laboratory
of the I.N.R.C.A. Hospital, Ancona, Italy and at the
Medical Laboratory of the Sant’Orsola-Malpighi
Hospital, Bologna, Italy.
Overnight fasting venous blood samples of all
subjects were collected from 8:00 to 9:00 a.m.
The samples were either analysed immediately or
stored at −80°C for no longer than 30 days.
Statistical analysis
Statistical analyses were performed according to the
following steps: In the first step, differences among
the groups were assessed by univariate analysis using
ANOVA with multiple comparisons (Dunnett’s t test)
in healthy subjects (Dunnett 1980) and centenarians
while a t test in T2DM patients. TG and CRP levels
were not normally distributed and log-transformed for
statistical analyses.
In the second step, EFAwas used to investigate the
relationships between several correlated variables by
identifying underlying factors for each age group, and
principal component analysis (PCA) was used to extract
the initial set of components (Costello and Osborne
2005). PCA transformed a set of correlated variables
into a linear combination which accounted for both the
maximum proportion of the total variance and a new set
of uncorrelated components. The eigenvalues with a
value >1.0 were retained in the analysis. A Varimax
orthogonal rotation was used in this analysis to
obtain the factors. To interpret the results from factor
analysis, the pattern of the factor loading was examined
to determine which original variables represented
primary constituents of each factor.
Lastly, in the third step, SEM was applied to
confirm the factor solutions for each age group. Amodel
representative of the biological parameters (indicators)
and the corresponding factors coming from EFA
solutions was constructed. After evaluating the improve-
ment of fit from an independent to a hypothesized
model, the primary goal was to determine the ‘goodness
of fit’ between the hypothesized structural model and
the sample data. The confirmatory approach allowed to
test for a priori hypothesis and explicitly defines the
association between indicators and factors (latent
variables) (Tabachnick and Fidel 2001).
SEM is a statistical method employing factor
analysis and linear regression techniques to assess
the ‘fit’ of a model to the data. SEM is an extension of
general linear model that enables to examine more
complex relationships. The hypothesized model is
presented in path diagrams where circles represent
latent variables and residuals and rectangles represent
measured variables (indicators). Causal effects are
represented by single-headed arrows in the path diagram
while correlations are associated with double-headed
curved arrows. Absence of a line connecting variables
implies no hypothesized direct effect (Bollen 1989).
Maximum likelihood estimation was employed to
estimate all models. The first step of the SEM analysis
was to evaluate the independency of the model by
testing the hypothesis that there was no correlation
among all variables. In the second step, the hypothesized
model was tested and a chi-square difference test was
calculated to verify an improvement in the ‘fit’ between
independent and the hypothesized models.
The adequacy of model fit was evaluated using the
following statistics to assess the degree of fit between
estimated and observed variance: chi-square likelihood
ratio statistic, Normed Fit Index (NFI), the goodness-
of-fit index (GFI) and root mean square error of
approximation (RMSEA).
The NFI reflects the proportion by which the
hypothesized model improves fit compared to the
independence model. NFI values above 0.95 are
good and between 0.80 and 0.95 are acceptable.
GFI gives a measure of the accounted variance by
the model varying from 0 to 1, and it should be
equal to or greater 0.95 to accept hypothesized model.
The RMSEA decreases with increasingly good fit.
RMSEA provides a ‘rule of thumb’ cutoff for model
adequacy of <0.08. Data analysis was performed using
the SPSS/Win program version 17 (Spss Inc., Chicago,
IL, USA) and AMOS version 6 (Analysis of Moment
Structures). The level of statistical significance was
defined by a two-tailed p value <0.05.
Results
Table 1 reports the age-related mean levels across
age of selected biomarkers in healthy and T2DM
participants. In healthy subjects, FIBR and CRP
significantly increased with advancing age, while
WBCC did not show any significant difference.
GLU and Hb (males) were higher in old compared
to adults. TC and Hb were lower in the oldest old,
and GLU, TC and Hb were lower in centenarians
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respect to adults. TG levels were increased in older
and oldest old, but not in centenarians.
Table 2 shows plasma levels of the same bio-
markers in participants with T2DM according to age.
GLU levels were significantly lower and FIBR levels
significantly higher in old compared to adults. There
were no substantial differences observed for other
biomarkers across age.
Exploratory factorial analysis
Table 3 reports findings from the exploratory factor
analysis of all biomarkers. Three factors were observed
in groups of adults and old healthy subjects, while the
group of oldest old showed two distinct factors. In
the group of adults, parameters were associated
with three factors as factor 1 Hb, TG and GLU
(explained variance 27.0%), factor 2 FIBR and
CRP (explained variance 17.10%) and factor 3 TC
and WBCC (explained variance 16.3%). TG and
WBCC were loaded in more than one factor.
In the old group, parameters associated with three
factors were factor 1 as FIBR, CRP and WBCC
(explained variance 24.4%); factor 2 as TG, TC and
Hb (explained variance 18.6%) and factor 3 as Hb,
GLU and WBCC (explained variance 15.2%). In this
group of subjects, WBCC was associated with factors
1 and 3, while Hb was associated with factor 2 and
factor 3 (Table 3).
In the oldest old group, parameters associated with
two factors were factor 1 as TC, TG, Hb and GLU
(explained variance 26.7%) and factor 2 as WBCC,
CRP and FIBR (explained variance 23.6%). GLU was
loaded in both factors (Table 3).
Table 2 Clinical biomarkers in adults with T2DM according to age
Adult diabetics ≤65 years (n0235) Old diabetics 66–85 years (n0298)
Plasma glucose (mg/dl) 169.62±53.04 159.40±45.46*
Total cholesterol (mg/dl) 208.68±38.18 205.70±37.60
Triglycerides (mg/dl) 148.06±135.42 133.62±83.75
Haemoglobin (g/dl) (men) 14.96±1.11 14.83±1.28
Haemoglobin (g/dl) (women) 13.82±1.03 13.45±1.19
Fibrinogen (mg/dl) 293.54±70.75 311.92±83.26**
White blood cells (103/mm3) 6.77±1.66 6.62±1.58
C-reactive protein (mg/dl) 0.42±0.53 0.46±0.73
Data are presented as mean ± standard deviation
*p<0.05; **p<0.01 vs. ≤65 years for diabetic patients
Table 1 Clinical biomarkers in healthy subjects according to age
Adult
≤65 years
(n0421)
Old 66–85 years
(n0642)
Oldest old
86–98 years
(n0262)
Centenarians
>99 years
(n0279)
Plasma glucose (mg/dl) 91.42±10.90 100.71±30.41** 95.93±34.37 88.25±25.31*
Total cholesterol (mg/dl) 211.81±40.56 214.08±42.09 196.35±39.82** 186.22±40.49**
Triglycerides (mg/dl) 104.96±67.98 129.24±66.59** 111.97±55.52** 113.75±57.67
Haemoglobin (g/dl) (men) 14.06±1.30 14.42±1.38** 13.45±1.71** 12.77±1.33**
Haemoglobin (g/dl) (women) 14.23±1.77 13.52±1.33** 12.82±1.71** 12.34±1.76**
Fibrinogen (mg/dl) 297.19±68.60 336.75±89.87** 391.86±103.12** 394.07±134.51**
White blood cells (103/mm3) 6.29±1.62 6.22±1.76 6.47±1.98 6.11±2.02
C-reactive protein (mg/dl) 0.33±0.49 0.58±1.11** 0.98±1.70** 0.75±1.15**
Data are presented as mean ± standard deviation
*p<0.05; **p<0.01 vs ≤65 years
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Findings from the PCA explained 60% of variance
in adults and old and 50% in the group of oldest
old, suggesting increased variability over ageing.
Centenarians revealed a three-factorial structure
explaining 58.5% of total variance. The first factor
was related to TC, TG and Hb (explained variance
23.1%), the second one to WBCC CRP and GLU
(explained variance 19.7%) and the third one to
FIBR with CRP (factor loading00.329) (explained
variance 15.6%) (Table 3).
In the T2DM, adults had a factor structure that
accounted for 57.4%, of the total explained variance,
with three factors, where the first one loaded FIBR,
CRP and WBCC (explained variance 23.9%); the
second factor (explained variance 18.3%) was related
to GLU, Hb and TG that also loaded the third one
(explained variance 15.2%) together with TC. In the
old T2DM group, we found a two-factorial structure
explaining 44.2% of total variance, where the first was
related to FIBR, CRP and WBCC (explained variance
25.6%) and the second one to GLU, TC and TG
(explained variance 18.6%) (Table 3). Figure 1a–f
depicts age-related cluster patterns of the variables in
three age-groups of healthy subjects, centenarians and
T2DM, respectively.
Structural equation modelling
Figure 2a–d shows the path diagrams for each age
group of healthy subjects. The SEM statistics in the
final models are shown in Table 4. On the basis of
EFA results, three-factor models were hypothesized
for adult and old subjects, while a two-factor model
for the oldest old group.
The adult group showed that GLU, Hb and TG
were indicators of factor 1, CRP and FIBR of factor 2
and TC and WBCC of factor 3. In Table 4, a chi-square
difference test indicated a significant improvement
in fit between the independent and the hypothesized
model. All fit indices (NFI, GFI and RMSA) indicated
well fit to the data.
The old group had the following results: CRP,
WBCC and FIBR were indicators of factor 1, TC
and TG of factor 2 and GLU and Hb of factor 3. The
old group also had a structural model suggesting
three pathways. Chi-square difference test (Table 4)
indicates a significant improvement in fit between
the independent and the hypothesized model. All fit
indices show good fit to the data. The structures ofTa
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the relationship among the indicators are simpler
respect to the adult group.
The oldest old group results showed that Hb, TG
and TC were indicators of factor 1 and CRP, FIBR
and WBCC of factor 2. Considering that from the
EFA and GLU loaded as the first and second factor,
we hypothesized a structural model with GLU that
directly connected with other latent biomarkers. The
path diagram shows the impact of glucose in the
assessment of the first and second factors.
Path diagram of centenarians (panel d) suggests that
TC, Hb and TG were indicators of factor 1, WBCC
and GLU of factor 2 and PCR and FIBR of factor 3.
SEM statistics in the centenarian model show good fit
to the data. Centenarians revealed three structural
pathway models similar to adults and old groups.
In Fig. 2e, f depicts path diagrams for each age
group of T2DM patients. The adults of the T2DM
group had a similar structure to old healthy group
suggesting three pathways. The old T2DM group
had a similar structure to oldest old healthy group
suggesting two pathways. All fit indices showed good
fit to the data (Table 4).
Conclusions
The use of exploratory factor analysis and structural
equation modelling revealed an important factorial
structure of population changes over ageing in a large
sample of older individuals. In addition, the model
structure of both the T2DM and the centenarian
group was performed in order to observe model
structure changes in the presence of an age-related
disease and in centenarians such as a model of
successful ageing. In particular, three-factor structures
were identified in adults and old healthy subjects, while
two-factor structures were found in the oldest old,
suggesting reduced complexity of metabolic pathways
during ageing. There was a parallel decline in the
explained variance over ageing ranging from 60% to
50%, which suggests an increased level of variability.
The factor including inflammatory variables, such
as CRP, FIBR and WBCC, explained a higher level
of variance in the old and in the oldest old respect
to the adults. These findings confirm the inevitable
increase in a pro-inflammatory state over human
ageing.
Fig. 1 Cluster pattern of selected variables in healthy people
and diabetic patients according to age. Venn diagrams of the
exploratory factor analysis for both study groups according
to age. The circle diameters assess the explained variance
for each factors and the overlap pictures the relationship
between selected variables and factors shown on Table 3.
Selected variables: fasting plasma glucose (GLU; milligrams
per decilitre), total cholesterol (TC; milligrams per decilitre),
triglycerides (TG; milligrams per decilitre), fibrinogen (FIBR;
milligrams per decilitre), C-reactive protein (CRP; milligrams
per decilitre), white blood cell count (WBCC; 103/mm3) and
haemoglobin (Hb; grams per decilitre). The sample of 1,325
healthy subjects was categorized according to age in four groups
as follows: adult (≤65 years) (n0421), old (66–85 years) (n0642),
oldest old (86–98 years) (n0262) and centenarians (>99 years)
(n0279). T2DM group was categorized according to age as
follows: adult (≤65 years) (n0235) and old (66–85 years)
(n0298)
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Recently, different results were reported on inflam-
matory ‘component’ in older populations and its
relationship with the measures of physical function
(Bandeen-Roche et al. 2009; Hsu et al. 2009). Hsu
et al. (2009) showed that inflammatory components
have inconsistent associations with different aspects
of physical performance, whereas Bandeen-Roche
showed that an increased up-regulation of inflammatory
mediators was significantly associated with a reduction
in the mean mobility score. These authors analysed
pro-inflammatory serum/plasma markers, such as
IL-1β, TNF-α, IL-6, IL-18 and CRP. Unfortunately,
these cytokines were not included in our protocol
since their measures are not currently standardized.
Indeed, CRP was included in our analysis since this
protein is directly stimulated by pro-inflammatory
cytokines and its measure is standardized for clinical
diagnosis. We also included fibrinogen and white blood
cell count which were obtained from standardized blood
tests and are easily available. Interestingly, CRP and
fibrinogen showed an age-related increase in healthy
subjects, and fibrinogen was higher in young compared
to older persons with T2DM. Moreover, the percentage
of variability, explained by the inflammatory factor,
increases with age supporting the hypothesis of
‘inflammaging’ (Franceschi et al. 2000; Salvioli et al.
2009). Interestingly, the inflammatory component was a
significant determinant in the oldest old of healthy sub-
jects and in old T2DM participants. This finding further
highlights that a pro-inflammatory condition is acceler-
ated in older persons with an age-related disease, such as
T2DM. In the old and oldest groups, the inflammatory
component was the first factor, whereas in centenarians
it was the second one. This finding supports the hypoth-
esis that a specific genetic anti-inflammatory pattern is
present in centenarians which leads to lower production
of pro-inflammatory levels in the general ageing popu-
lation (Candore et al. 2010; Salvioli et al. 2006; Bonafè
and Olivieri 2009).
Our data also showed that in the oldest old group of
healthy subjects, glucose levels weighted the two
factors in the same proportion (Fig. 2c), characterizing
the importance of glucose metabolism in this population
and suggesting that all selected variables were closely
related to glucose levels. Intriguingly, glucose metabo-
lism in healthy centenarians has been shown to be better
than that of older individuals (Barbieri et al. 2003;
Yashin et al. 2009). This observation could suggest that
an efficient metabolic (energetic) pathway is needed to
achieve longevity because all biological variables are
directly related to glucose levels in the oldest age. It is
hypothesized from studies of model organisms,
short-term studies of humans and human epidemiologic
data that two potent modulators of longevity in
humans are insulin/insulin-like growth factor 1
Fig. 2 Path diagrams for each age group of healthy subjects and
diabetic patients. SEM models of the exploratory factor analysis
for both study groups according to age. Circles represent factors
(1, 2, 3) and residuals (b, d, e,), and rectangles represent
selected variables: fasting plasma glucose (GLU; milligrams
per decilitre), total cholesterol (TC; milligrams per decilitre),
triglycerides (TG; milligrams per decilitre), fibrinogen (FIBR;
milligrams per decilitre), C-reactive protein (CRP; milligrams
per decilitre), white blood cell count (WBCC; 103/mm3) and
haemoglobin (Hb; grams per decilitre). The single-headed arrow
represents causal relationship. Double-headed curved arrow
represents the correlation. Numbers on double-headed curved
arrows are correlation coefficients. Numbers on single-headed
curved arrows are standardized regression coefficients. Numbers
over the rectangles are R2 values. The sample of 1,325 healthy
subjects was categorized according to age in four groups as
follows: adult (≤65 years) (n0421), old (66–85 years) (n0642),
oldest old (86–98 years) (n0262) and centenarians (>99 years)
(n0279). T2DM group was categorized according to age as
follows: adult (≤65 years) (n0235) and old (66–85 years)
(n0298)

Table 4 Fit indices for all models
Model H0 χ
2 (DF) χ2 (DF) NFI GFI RMSA (90% CLs)
Adult ≤65 years 266.024 (21) 16.721 (6) 0.937 0.989 0.064 (0.029–0.103)
Old 66–85 years 313.978 (21) 27.170 (9) 0.913 0.987 0.067 (0.042– 0.095)
Oldest old 86–98 years 149.416 (21) 28.002 (9) 0.813 0.968 0.075 (0.039–0.112)
Centenarians 98.023 (21) 13.432 (11) 0.863 0.979 0.062 (0.000–0.114)
Adult diabetics ≥65 years 94.280 (21) 14.498 (10) 0.850 0.980 0.059 (0.000–0.107)
Old diabetics 66–85 years 183.696 (21) 13.434 (13) 0.927 0.988 0.011 (0.001–0.059)
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(IGF-1) signalling and dietary restriction (Bonafè and
Olivieri 2009; Fontana and Klein 2007; Roth et al.
2004; Willcox et al. 2007). It was suggested that these
two pathways are intricately connected and both the
insulin/IGF-1 pathway and the pathway that mediates
the effects of dietary restriction have evolved to respond
to the nutritional status of an organism, which in turn
affects the lifespan (Narasimhan et al. 2009). Therefore,
a fine regulation of glucose metabolism is required to
maintain health as well as achieve longevity (Yashin et
al. 2009).
All presented results are most likely explained by
the combined effects of selective and remodelling forces
towards achieving human longevity and are in accor-
dance with the observation that healthy physiological
processes require the complex interaction of multiple
control systems operating over multiple time scales,
while the ageing process itself and disease are
associated with a loss of complexity in the dynamics
of many physiological systems. This loss of complexity
may reduce the ability to adapt to stress and lead to
frailty. It can be hypothesized that the age-related
diseases, such as T2DM, are states of critically
impaired homeostasis resulting in an increased
vulnerability towards stressors. On the contrary,
genetically selected healthy older adults maintain
a higher level of complexity and are more able to
interact with environmental stressors. Future research
will determine whether the creation of biomarker
indices can improve multiple aspects of physiological
complexity underlying human ageing process,
screening and monitoring of clinical vulnerability
in older adults.
Limitations
Our study included the most commonly used clinical
biomarkers. However, we cannot exclude that additional
biomarkers could be related to the factorial structure of
the sample. Moreover, our data suggest an age-related
decrease of complexity and a concomitant increase of
variability that may be the result of the combined
effects of selective and remodelling forces (genetic
and environment) on reaching longevity. Considering
the cross-sectional design of our study, we cannot
discriminate between a genetic and a remodelling
effect on factorial structure of the samples. A larger
longitudinal study in older persons will be necessary.
References
American Diabetes Association (2007) Diagnosis and classifi-
cation of diabetes mellitus. Diabetes Care 30:S42–S47
Bandeen-Roche K, Walston JD, Huang Y, Semba RD, Ferrucci
L (2009) Measuring systemic inflammatory regulation
in older adults: evidence and utility. Rejuvenation Res
12:403–410
Barbieri M, Rizzo MR, Manzella D, Paolisso G (2001) Age-
related insulin resistance: is it an obligatory finding? The
lesson from healthy centenarians. Diabetes Metab Res Rev
17:19–26
Barbieri M, Rizzo MR, Manzella D et al (2003) Glucose regula-
tion and oxidative stress in healthy centenarians. Exp
Gerontol 38:137–143
Bollen KA (1989) Structural equations with latent variables.
Wiley, New York
Bonafè M, Olivieri F (2009) Genetic polymorphism in long-lived
people: cues for the presence of an insulin/IGF-pathway-
dependent network affecting human longevity. Mol Cell
Endocrinol 299:118–123
Candore G, Caruso C, Colonna-Romano G (2010) Inflamma-
tion, genetic background and longevity. Biogerontology
11:565–573
Capri M, Salvioli S, Sevini F, Valensin S, Celani L, Monti D,
Pawelec G, De Benedictis G, Gonos ES, Franceschi C
(2006) The genetics of human longevity. Ann N Y Acad
Sci 1067:252–263
Capri M, Salvioli S, Monti D, Caruso C, Candore G, Vasto S,
Olivieri F, Marchegiani F, Sansoni P, Baggio G, Mari D,
Passarino G, De Benedictis G, Franceschi C (2008) Human
longevity within an evolutionary perspective: the peculiar
paradigm of a post-reproductive genetics. Exp Gerontol
43:53–60
Cevenini E, Bellavista E, Tieri P, Castellani G, Lescai F,
Francesconi M,Mishto M, Santoro A, Valensin S, Salvioli S,
Capri M, Zaikin A, Monti D, de Magalhães JP, Franceschi C
(2010) Systems biology and longevity: an emerging
approach to identify innovative anti-aging targets and
strategies. Curr Pharm Des 16(7):802–813
Choi KM, Lee J, Kim KB, Kim DR, Kim SK, Shin DH, Kim
NH, Park IB, Choi DS, Baik SH, South-west Seoul Study
(2003) Factor analysis of the metabolic syndrome among
elderly Koreans—the South-west Seoul Study. Diabet Med
20:99–104
Costello AB, Osborne J (2005) Best practices in exploratory
factor analysis: four recommendations for getting the most
from your analysis. Pract Assess Res Eval 10(7):1–9
de Magalhães JP, Budovsky A, Lehmann G, Costa J, Li Y,
Fraifeld V, Church GM (2009a) The Human Ageing Genomic
Resources: online databases and tools for biogerontologists.
Aging Cell 8:65–72
de Magalhães JP, Curado J, Church GM (2009b) Meta-analysis
of age-related gene expression profiles identifies common
signatures of aging. Bioinformatics 25:875–881
Dunnett CW (1980) A multiple comparison procedure for
comparing several treatments with a control. J Am Stat
Assoc 50:1096–1121
Fontana L, Klein S (2007)Aging, adiposity, and calorie restriction.
JAMA 297:986–994
428 AGE (2013) 35:419–429
Franceschi C (2007) Inflammaging as a major characteristic of
old people: can it be prevented or cured? Nutr Rev 65:
S173–S176
Franceschi C, Valensin S, Bonafe M et al (2000) The network and
the remodeling theories of aging: historical background and
new perspectives. Exp Gerontol 35:879–896
Franceschi C, Bezrukov V, Blanché H, Bolund L, Christensen
K, de Benedictis G, Deiana L, Gonos E, Hervonen A, Yang
H, Jeune B, Kirkwood TB, Kristensen P, Leon A, Pelicci
PG, Peltonen L, Poulain M, Rea IM, Remacle J, Robine
JM, Schreiber S, Sikora E, Slagboom PE, Spazzafumo L,
Stazi MA, Toussaint O, Vaupel JW (2007a) Genetics of
healthy aging in Europe: the EU-integrated project GEHA
(Genetics of Healthy Aging). Ann N YAcad Sci 1100:21–45
Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F,
Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E,
Castellani GC, Salvioli S (2007b) Inflammaging and
anti-inflammaging: a systemic perspective on aging and
longevity emerged from studies in humans. Mech Ageing
Dev 128:92–105
Frisoni GB, Franzoni S, Rozzini R et al (1994) A nutritional
index predicting mortality in the nursing home. J Am
Geriatr Soc 42:1167–1172
Gögele M, Pattaro C, Fuchsberger C, Minelli C, Pramstaller PP,
Wjst M (2011) Heritability analysis of life span in a semi-
isolated population followed across four centuries reveals
the presence of pleiotropy between life span and reproduc-
tion. J Gerontol A Biol Sci Med Sci 66(1):26–37
Hasegawa T, Nakasato Y, Sasaki M (2005) Factor analysis of
lifestyle-related factors in 12,525 urban Japanese subjects.
J Atheroscler Thromb 12:29–34
Hsu FC, Kritchevsky SB, Liu Y, Kanaya A, Newman AB, Perry
SE, Visser M, Pahor M, Harris TB, Nicklas BJ, Health
ABC Study (2009) Association between inflammatory
components and physical function in the health, aging,
and body composition study: a principal component
analysis approach. J Gerontol A Biol Sci Med Sci 64:581–
589
Khader YS, Batieha A, Jaddou H, Batieha Z, El-Khateeb M,
Ajlouni K (2011) Factor analysis of cardiometabolic risk
factors clustering in children and adolescents. Metab Syndr
Relat Disord 9:151–156
Mackinnon A, Christensen H, Jorm AF (2006) Search for a
common cause factor amongst cognitive, speed and
biological variables using narrow age cohorts. Gerontology
52:243–257
Nakamura E, Miyao K (2003) Further evaluation of the basic
nature of the human biological aging process based on a
factor analysis of age-related physiological variables. J
Gerontol A Biol Sci Med Sci 58:196–204
Narasimhan SD, Yen K, Tissenbaum HA (2009) Converging
pathways in lifespan regulation. Curr Biol 19:R657–R666
Noale M, Maggi S, Marzari C, Limongi F, Gallina P, Bianchi D,
Crepaldi G, ILSA Working Group (2006) Components of
the metabolic syndrome and incidence of diabetes in
elderly Italians: the Italian Longitudinal Study on Aging.
Atherosclerosis 187:385–392
O’Hea EL, Bodenlos JS, Moon S, Grothe KB, Brantley PJ
(2009) The multidimensional health locus of control scales:
testing the factorial structure in sample of African American
medical patients. Ethn Dis 19:192–198
Passarino G, Montesanto A, De Rango F et al (2007) A cluster
analysis to define human aging phenotypes. Biogerontology
8:283–290
Pawlikowska L, Hu D, Huntsman S, Sung A, Chu C, Chen J,
Joyner AH, Schork NJ, Hsueh WC, Reiner AP, Psaty BM,
Atzmon G, Barzilai N, Cummings SR, Browner WS,
Kwok PY, Ziv E (2009) Study of Osteoporotic Fractures.
Association of common genetic variation in the insulin/
IGF1 signaling pathway with human longevity. Aging Cell
8:460–472
Rabini RA, Moretti N, Staffolani R et al (2002) Reduced
susceptibility to peroxidation of erythrocyte plasma
membranes from centenarians. Exp Gerontol 37(5):657–663
Riechelmann H, Deutschle T, Rozsasi A, Keck T, Polzehl
D, Bürner H (2005) Nasal biomarker profiles in acute
and chronic rhinosinusitis. Clin Exp Allergy 35:1186–
1191
Roth GS, Mattison JA, Ottinger MA, Chachich M, Lane MA,
Ingram DK (2004) Aging in rhesus monkeys: relevance to
human health interventions. Science 305:1423–1426
Salvioli S, Olivieri F, Marchegiani F, Cardelli M, Santoro A,
Bellavista E, Mishto M, Invidia L, Capri M, Valensin S,
Sevini F, Cevenini E, Celani L, Lescai F, Gonos E, Caruso
C, Paolisso G, De Benedictis G, Monti D, Franceschi C
(2006) Genes, ageing and longevity in humans: problems,
advantages and perspectives. Free Radic Res 40:1303–1323
Salvioli S, Capri M, Bucci L, Lanni C, Racchi M, Uberti D,
Memo M, Mari D, Govoni S, Franceschi C (2009) Why do
centenarians escape or postpone cancer? The role of IGF-1,
inflammation and p53. Cancer Immunol Immunother
58:1909–1917
Schachter F, Faure-Delanef L, Guenot F et al (1994) Genetic
associations with human longevity at the APOE and ACE
loci. Nat Genet 6(1):29–32
Singh R, Kolvraa S, Rattan SI (2007) Genetics of human
longevity with emphasis on the relevance of HSP70 as
candidate genes. Front Biosci 12:4504–4513
Suzuki M, Willcox DC, Rosenbaum MW, Willcox BJ (2010)
Oxidative stress and longevity in Okinawa: an investi-
gation of blood lipid peroxidation and tocopherol
in Okinawan centenarians. Curr Gerontol Geriatr Res
2010:380460
Tabachnick BG, Fidel LS (2001) Using multivariate statistics.
Allyn & Bacon, Needham Heights
Wang JJ, Qiao Q, Miettinen ME et al (2004) The metabolic
syndrome defined by factor analysis and incident type 2
diabetes in a Chinese population with high postprandial
glucose. Diabetes Care 27:2429–2437
Willcox BJ, Willcox DC, Todoriki H, Fujiyoshi A, Yano K,
He Q, Curb JD, Suzuki M (2007) Caloric restriction,
the traditional Okinawan diet, and healthy aging: the
diet of the world’s longest-lived people and its potential
impact on morbidity and life span. Ann N Y Acad Sci
1114:434–455
Willcox BJ, Donlon TA, He Q et al (2008) FOXO3A genotype
is strongly associated with human longevity. Proc Natl
Acad Sci U S A 105(37):13987–13992
Yashin AI, Arbeev KG, Akushevich I, Ukraintseva SV, Kulminski
A, Arbeeva LS, Culminskaya I (2009) Exceptional survivors
have lower age trajectories of blood glucose: lessons from
longitudinal data. Biogerontology 11:257–265
AGE (2013) 35:419–429 429
